By Nascent Biotech Posted November 9, 2019 In BJCR-104(10) copy2019-11-092019-11-09http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 BJCR-104(10) copy Recent PostsNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical ResearchNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
